126 related articles for article (PubMed ID: 11512643)
1. Prolonged thiopentone infusion for neurosurgical emergencies: usefulness of therapeutic drug monitoring.
Cordato DJ; Herkes GK; Mather LE; Gross AS; Finfer S; Morgan MK
Anaesth Intensive Care; 2001 Aug; 29(4):339-48. PubMed ID: 11512643
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of thiopentone enantiomers following intravenous injection or prolonged infusion of rac-thiopentone.
Cordato DJ; Gross AS; Herkes GK; Mather LE
Br J Clin Pharmacol; 1997 Apr; 43(4):355-62. PubMed ID: 9146846
[TBL] [Abstract][Full Text] [Related]
3. Elimination of methohexitone after long-term, high-dose infusion in patients with critically elevated intracranial pressure.
Schickendantz J; Funk W; Ittner KP; Gruber M; Taeger K; Kees F
Crit Care Med; 1999 Aug; 27(8):1570-6. PubMed ID: 10470766
[TBL] [Abstract][Full Text] [Related]
4. Cerebral protection with thiopentone during combined carotid endarterectomy and clipping of intracranial aneurysm.
McConkey PP; Kien ND
Anaesth Intensive Care; 2002 Apr; 30(2):219-22. PubMed ID: 12002933
[TBL] [Abstract][Full Text] [Related]
5. Thiopental in CSF and serum correlates with prolonged loss of cortical activity.
Stover JF; Lenzlinger PM; Stocker R; Morganti-Kossmann MC; Imhof HG; Trentz O; Kossmann T
Eur Neurol; 1998; 39(4):223-8. PubMed ID: 9635473
[TBL] [Abstract][Full Text] [Related]
6. Placental transfer and pharmacokinetics of thiopentone in newborn infants.
Norman E; Westrin P; Fellman V
Arch Dis Child Fetal Neonatal Ed; 2010 Jul; 95(4):F277-82. PubMed ID: 20488867
[TBL] [Abstract][Full Text] [Related]
7. Barbiturates for acute neurological and neurosurgical emergencies--do they still have a role?
Cordato DJ; Herkes GK; Mather LE; Morgan MK
J Clin Neurosci; 2003 May; 10(3):283-8. PubMed ID: 12763328
[TBL] [Abstract][Full Text] [Related]
8. Dyskalaemia associated with thiopentone barbiturate coma for refractory intracranial hypertension: a case series.
Ng SY; Chin KJ; Kwek TK
Intensive Care Med; 2011 Aug; 37(8):1285-9. PubMed ID: 21567112
[TBL] [Abstract][Full Text] [Related]
9. High-dose thiopentone for open-chamber cardiac surgery: a retrospective review.
Pascoe EA; Hudson RJ; Anderson BA; Kassum DA; Shanks A; Rosenbloom M; Thomson IR
Can J Anaesth; 1996 Jun; 43(6):575-9. PubMed ID: 8773863
[TBL] [Abstract][Full Text] [Related]
10. Barbiturate infusion for intractable intracranial hypertension and its effect on brain oxygenation.
Chen HI; Malhotra NR; Oddo M; Heuer GG; Levine JM; LeRoux PD
Neurosurgery; 2008 Nov; 63(5):880-6; discussion 886-7. PubMed ID: 19005378
[TBL] [Abstract][Full Text] [Related]
11. Non linear disposition of thiopentone following long-term infusion.
Le Corre P; Malledant Y; Tanguy M; Le Verge R
Eur J Drug Metab Pharmacokinet; 1993; 18(3):255-9. PubMed ID: 8149943
[TBL] [Abstract][Full Text] [Related]
12. Pharmacologic Treatment Reduces Pressure Times Time Dose and Relative Duration of Intracranial Hypertension.
Colton K; Yang S; Hu PF; Chen HH; Bonds B; Stansbury LG; Scalea TM; Stein DM
J Intensive Care Med; 2016 May; 31(4):263-9. PubMed ID: 25320157
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of thiopental enantiomers during and following prolonged high-dose therapy.
Cordato DJ; Mather LE; Gross AS; Herkes GK
Anesthesiology; 1999 Dec; 91(6):1693-702. PubMed ID: 10598612
[TBL] [Abstract][Full Text] [Related]
14. Electroencephalographic effects of thiopentone and its enantiomers in the rat: correlation with drug tissue distribution.
Mather LE; Edwards SR; Duke CC
Br J Pharmacol; 1999 Sep; 128(1):83-91. PubMed ID: 10498838
[TBL] [Abstract][Full Text] [Related]
15. Thiopental pharmacokinetics under conditions of long-term infusion.
Turcant A; Delhumeau A; Premel-Cabic A; Granry JC; Cottineau C; Six P; Allain P
Anesthesiology; 1985 Jul; 63(1):50-4. PubMed ID: 4014770
[TBL] [Abstract][Full Text] [Related]
16. [Thiopental kinetics in high-dose use].
Taeger K; Murr R; Schmiedeck P; Jensen U; Peter K
Anasth Intensivther Notfallmed; 1986 Oct; 21(5):237-44. PubMed ID: 3799947
[TBL] [Abstract][Full Text] [Related]
17. Thiopentone elimination in newborn infants: exploring Michaelis-Menten kinetics.
Larsson P; Anderson BJ; Norman E; Westrin P; Fellman V
Acta Anaesthesiol Scand; 2011 Apr; 55(4):444-51. PubMed ID: 21342147
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of infusion regimens for thiopentone as a primary anaesthetic agent.
Crankshaw DP; Edwards NE; Blackman GL; Boyd MD; Chan HN; Morgan DJ
Eur J Clin Pharmacol; 1985; 28(5):543-52. PubMed ID: 4043199
[TBL] [Abstract][Full Text] [Related]
19. Sedation with intravenous infusions of propofol or thiopentone. Effects on pain perception.
Wilder-Smith OH; Kolletzki M; Wilder-Smith CH
Anaesthesia; 1995 Mar; 50(3):218-22. PubMed ID: 7717487
[TBL] [Abstract][Full Text] [Related]
20. [Prolonged cerebral electrical "silence" with intracranial pressure monitored by extradural approach in the treatment of post-traumatic coma using thiopentone combined with alphaxalone-alphadolone. Clinical case].
Demo P; Pellizzari A; Coppola L; Vendramin ML
Minerva Anestesiol; 1985 Oct; 51(10):503-8. PubMed ID: 3831810
[No Abstract] [Full Text] [Related]
[Next] [New Search]
